Showing results (371-380 of 498) with videos related to

Sort By:
Pageof 50
Leukemia & Lymphoma|June 8, 2019
A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)Byeong-Bae Park, Won Seog Kim, Cheolwon Suh, et al.
Japanese Journal of Clinical Oncology|February 11, 2004
Early concurrent chemoradiotherapy with prolonged oral etoposide and cisplatin for limited-stage small-cell lung cancerSe-Hoon Lee, Yong Chan Ahn, Ho Joong Kim, et al.
Oncotarget|February 3, 2017
The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBPHyunchul Jung, Hae Yong Yoo, Seung Ho Lee, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2020
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphomaKyoung Ha Kim, Won Seog Kim, Seok Jin Kim, et al.
Oncotarget|September 15, 2018
Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations inHyunchul Jung, Hae Yong Yoo, Seung Ho Lee, et al.
Blood|June 26, 2020
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphomaHyera Kim, Hyehyun Jeong, Motoko Yamaguchi, et al.
Blood Advances|May 10, 2023
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project NetworkGreg Hapgood, Monica Civallero, Yana Stepanishyna, et al.
European Journal of Haematology|October 8, 2014
Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL)Sung-Hoon Jung, Je-Jung Lee, Won Seog Kim, et al.
BMC Cancer|November 12, 2019
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphomaSeok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, et al.
The Korean Journal of Internal Medicine|March 22, 2003
Adenocarcinoma of unknown primary siteSeo Young Song, Won Seog Kim, Hye Ran Lee, et al.
Pageof 50